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1. Introduction
The S100 protein family includes >20 low-molecular-
weight intracellular proteins containing an EF-hand 
motif and showing calcium-binding properties (Donato, 
2001). A recent study showed that S100 proteins play 
important roles in cancer malignancy and metastasis 
(Donato, 2003). Most S100 proteins perform several 
intracellular and extracellular functions. Intracellular 
functions of S100 proteins include regulation of calcium 
homeostasis, cell cycle, cell growth, and cell migration 
and regulation and phosphorylation of transcriptional 
factors. Extracellular function of S100 proteins is activated 
by the binding of tumor necrosis α (TNF-a), interleukin-1 
(IL-1), IL-6, chemokines, matrix metalloproteinases 
(MMPs), angiogenesis factors, and antiapoptotic proteins 
as cytokines to cell surface receptors (Chen et al., 2014). 
Three receptor types recognize S100 proteins, namely the 
receptor for advanced glycation end products (RAGE), 
Toll-like receptors (TLRs), and the extracellular MMP 
inducer (EMMPRIN) (Hiratsuka et al., 2008). RAGE is 
a multiligand receptor belonging to the immunoglobulin 
superfamily that is involved in inflammation, diabetes, 
atherosclerosis, nephropathy, neurodegeneration, and 
cancer (Sorci et al., 2004). S100A9, a member of the 
S100 protein family, interacts with RAGE, TLRs, and 
EMMPRIN (Sakaguchi et al., 2011). EMMPRIN is a 
well-known cell surface molecule associated with cancer 
cell malignancy (Gabison et al., 2005). The binding of 
S100A9 to EMMPRIN provides new insight into the 
molecular mechanism underlying S100A9–EMMPRIN-
mediated inflammation and melanoma cancer cell 
metastasis (Sakaguchi et al., 2011). EMMPRIN is also 
involved in fetal development, retinal function, nervous 
system development, and plaque formation in Alzheimer 
disease (Iacono et al., 2007). S100A9 is mainly expressed 
in myeloid cells and performs a key role in these cells 
under inflammatory conditions (Urban et al., 2009). In 
humans, serum levels of S100A9 increase during several 
disease conditions, including acute inflammatory lesions, 
cystic fibrosis, rheumatoid arthritis, and amyloids in the 
aging prostate gland (Vogl et al., 2012). Melanoma is 
the most aggressive type of skin cancer, involving a type 
Abstract: Increased levels of calprotectin subunits S100A8 and S100A9 have been detected in human cancers. Melanoma is the most 
aggressive type of skin cancer, and its treatment is challenging because of its brain metastasis. OCLN encodes occludin, which plays 
a major role in the formation and regulation of tight junctions. The aim of this study was to evaluate the methylation status of the 
OCLN promoter and its expression in A-375 melanoma cells treated with or without various concentrations of S100A9 for 24, 48, and 
72 h. Total RNA was extracted, and synthesized cDNA was assessed by performing real-time PCR. MSP-PCR was performed after 
treatment with bisulfite. Recombinant S100A9 inhibited the proliferation of the A-375 cell line and the expression of the OCLN gene 
was downregulated in a time- and concentration-dependent manner. Results of MSP-PCR showed that the OCLN gene promoter in a 
human melanoma cell line (A-375) was semimethylated. 
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